The outlook of companies tied to iconic drugs like Viagra presents a complex investment picture. While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial profits , the loss of exclusivity in key markets has introduced significant uncertainty . Investors are now facing the effect of rival medications , red